O'Brien S - Search Results

1

Results of inotuzumab ozogamicin, a CD22 monoclonal antibody, in refractory and relapsed acute lymphocytic leukemia.

Kantarjian H, Thomas D, Jorgensen J, Kebriaei P, Jabbour E, Rytting M, York S, Ravandi F, Garris R, Kwari M, Faderl S, Cortes J, Champlin R, O'Brien S. Kantarjian H, et al. Cancer. 2013 Aug 1;119(15):2728-36. doi: 10.1002/cncr.28136. Epub 2013 Apr 30. Cancer. 2013. PMID: 23633004 Free PMC article. Clinical Trial.

2

Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia.

Verstovsek S, Kantarjian H, Manshouri T, O'Brien S, Faderl S, Talpaz M, Cortes J, Albitar M. Verstovsek S, et al. Cancer. 2002 Mar 1;94(5):1517-21. doi: 10.1002/cncr.10363. Cancer. 2002. PMID: 11920509 Free article.

3

Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia.

O'Brien S, Talpaz M, Cortes J, Shan J, Giles FJ, Faderl S, Thomas D, Garcia-Manero G, Mallard S, Beth M, Koller C, Kornblau S, Andreeff M, Murgo A, Keating M, Kantarjian HM. O'Brien S, et al. Cancer. 2002 Apr 1;94(7):2024-32. doi: 10.1002/cncr.10436. Cancer. 2002. PMID: 11932905 Free article.

4

Complete cytogenetic and molecular responses to interferon-alpha-based therapy for chronic myelogenous leukemia are associated with excellent long-term prognosis.

Kantarjian HM, O'Brien S, Cortes JE, Shan J, Giles FJ, Rios MB, Faderl SH, Wierda WG, Ferrajoli A, Verstovsek S, Keating MJ, Freireich EJ, Talpaz M. Kantarjian HM, et al. Cancer. 2003 Feb 15;97(4):1033-41. doi: 10.1002/cncr.11223. Cancer. 2003. PMID: 12569603 Free article.

5

A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.

Cortes J, Kantarjian H, Albitar M, Thomas D, Faderl S, Koller C, Garcia-Manero G, Giles F, Andreeff M, O'Brien S, Keating M, Estey E. Cortes J, et al. Cancer. 2003 Mar 1;97(5):1234-41. doi: 10.1002/cncr.11180. Cancer. 2003. PMID: 12599230 Free article. Clinical Trial.

6

Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes.

Tsimberidou A, Estey E, Cortes J, Thomas D, Faderl S, Verstovsek S, Garcia-Manero G, Keating M, Albitar M, O'Brien S, Kantarjian H, Giles F. Tsimberidou A, et al. Cancer. 2003 Mar 15;97(6):1481-7. doi: 10.1002/cncr.11239. Cancer. 2003. PMID: 12627513 Free article. Clinical Trial.

7

Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience.

Lazo G, Kantarjian H, Estey E, Thomas D, O'Brien S, Cortes J. Lazo G, et al. Cancer. 2003 May 1;97(9):2218-24. doi: 10.1002/cncr.11314. Cancer. 2003. PMID: 12712474 Free article. Clinical Trial.

8

Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.

Cortes J, Giles F, O'Brien S, Thomas D, Albitar M, Rios MB, Talpaz M, Garcia-Manero G, Faderl S, Letvak L, Salvado A, Kantarjian H. Cortes J, et al. Cancer. 2003 Jun 1;97(11):2760-6. doi: 10.1002/cncr.11416. Cancer. 2003. PMID: 12767088 Free article.

9

Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside.

Garcia-Manero G, Talpaz M, Giles FJ, Cortes J, Faderl S, O'Brien S, Thomas D, Verstovsek S, Beth Rios M, Shan J, Ferrajoli A, Wierda W, Kantarjian HM. Garcia-Manero G, et al. Cancer. 2003 Jun 15;97(12):3010-6. doi: 10.1002/cncr.11424. Cancer. 2003. PMID: 12784336 Free article. Clinical Trial.

10

Phase 2 clinical and pharmacologic study of clofarabine in patients with refractory or relapsed acute leukemia.

Kantarjian H, Gandhi V, Cortes J, Verstovsek S, Du M, Garcia-Manero G, Giles F, Faderl S, O'Brien S, Jeha S, Davis J, Shaked Z, Craig A, Keating M, Plunkett W, Freireich EJ. Kantarjian H, et al. Blood. 2003 Oct 1;102(7):2379-86. doi: 10.1182/blood-2003-03-0925. Epub 2003 Jun 5. Blood. 2003. PMID: 12791647 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,097 results

Search Page

Filters